MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/1472-6904-9-17

Медицинская библиотека · BMC clinical pharmacology · 2009

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.

Adams James B, Baral Matthew, Geis Elizabeth, Mitchell Jessica, Ingram Julie, Hensley Andrea, Zappia Irene, Newmark Sanford, Gehn Eva, Rubin Robert A, Mitchell Ken, Bradstreet Jeff, El-Dahr Jane

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years.

METHODS

Phase 1 involved 65 children with ASD who received one round of DMSA (3 days). Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2. In phase 2, 49 participants were randomly assigned in a double-blind design to receive an additional 6 rounds of either DMSA or placebo.

RESULTS

The groups receiving one round and seven rounds of DMSA had significant improvements on all the assessment measures. For the seven round group, the degree of improvement on the assessment measures could be partially explained by a regression analysis based on excretion of toxic metals and changes in glutathione (adjusted R2 of 0.28-0.75, p < 0.02 in all cases). One round of DMSA had nearly the same benefit as seven rounds. The assessment measures correlated reasonably with one another at the beginning of the study (r = 0.60-0.87) and even better at the end of the study (r = 0.63-0.94).

CONCLUSION

Overall, both one and seven rounds of DMSA therapy seems to be reasonably safe in children with ASD who have high urinary excretion of toxic metals, and possibly helpful in reducing some of the symptoms of autism in those children.

Для цитирования: Adams James B, Baral Matthew, Geis Elizabeth, Mitchell Jessica, Ingram Julie, Hensley Andrea, Zappia Irene, Newmark Sanford, Gehn Eva, Rubin Robert A, Mitchell Ken, Bradstreet Jeff, El-Dahr Jane. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.. BMC clinical pharmacology. 2009. DOI: 10.1186/1472-6904-9-17.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.